MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-30-2025
AtriCure Market Cap 2011-2025 | ATRC
As of December 26, 2025 AtriCure has a market cap of $ 1.9 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap AtriCure
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.91 B | 1.52 B | 1.94 B | 2.96 B | 2.45 B | 1.52 B | 1.01 B | 547 M | 506 M | 490 M | 523 M | 426 M | 133 M | 182 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.96 B | 133 M | 1.15 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical instruments industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
17.3 B | $ 19.11 | 0.95 % | $ 9.75 B |  USA |
 |
Becton, Dickinson and Company
BDX
|
56.2 B | $ 196.12 | 0.23 % | $ 56.4 B | USA |
 |
Luminex Corporation
LMNX
|
1.27 B | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
809 K | - | -9.52 % | $ 20.6 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
9.68 M | $ 5.47 | 3.01 % | $ 110 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
727 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
2.27 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
152 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
6.07 B | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
15.6 B | - | -0.02 % | $ 16.3 B | USA |
 |
Harvard Bioscience
HBIO
|
188 M | $ 0.73 | 0.64 % | $ 31 M | USA |
 |
Alcon
ALC
|
42.6 B | $ 80.17 | 0.06 % | $ 40.4 B |  Schweiz |
 |
ICU Medical
ICUI
|
3.65 B | $ 146.98 | -0.35 % | $ 3.58 B | USA |
 |
Atrion Corporation
ATRI
|
639 M | - | - | $ 810 M | USA |
 |
electroCore
ECOR
|
29.4 K | $ 4.86 | 1.25 % | $ 26.8 K | USA |
 |
iRhythm Technologies
IRTC
|
3.49 B | $ 175.8 | -1.49 % | $ 5.48 B | USA |
 |
Isoray
ISR
|
24.5 M | - | 0.03 % | $ 108 M | USA |
 |
AngioDynamics
ANGO
|
355 M | $ 13.16 | - | $ 538 M | USA |
 |
The Cooper Companies
COO
|
16.3 B | $ 82.57 | -0.37 % | $ 16.4 B | USA |
 |
Repro Med Systems
KRMD
|
96.7 M | $ 6.48 | -0.61 % | $ 295 M | USA |
 |
Glaukos Corporation
GKOS
|
4.3 B | $ 116.64 | 0.4 % | $ 5.65 B | USA |
 |
LeMaitre Vascular
LMAT
|
2.07 B | $ 84.34 | 0.44 % | $ 1.89 B | USA |
 |
Haemonetics Corporation
HAE
|
3.06 B | $ 80.01 | -0.44 % | $ 4.03 B | USA |
 |
InfuSystem Holdings
INFU
|
146 M | $ 9.11 | 0.66 % | $ 188 M | USA |
 |
Masimo Corporation
MASI
|
8.96 B | $ 133.28 | -0.44 % | $ 7.1 B | USA |
 |
Merit Medical Systems
MMSI
|
5.94 B | $ 87.39 | -0.27 % | $ 5.09 B | USA |
 |
Intuitive Surgical
ISRG
|
203 B | $ 577.15 | -0.03 % | $ 205 B | USA |
 |
OraSure Technologies
OSUR
|
259 M | $ 2.43 | 2.53 % | $ 181 M | USA |
 |
Microbot Medical
MBOT
|
11.7 M | $ 2.18 | - | $ 22.2 M |  Israel |
 |
Milestone Scientific
MLSS
|
69.4 M | $ 0.29 | -0.48 % | $ 23.1 M | USA |
 |
Nephros
NEPH
|
22.5 M | $ 5.23 | 12.23 % | $ 54.3 M | USA |
 |
NeuroMetrix
NURO
|
8.71 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
3.68 B | $ 22.0 | 0.59 % | $ 3.79 B | USA |
 |
Predictive Oncology
POAI
|
8.29 M | - | - | $ 32.4 M | USA |
 |
Pro-Dex
PDEX
|
150 M | $ 40.4 | -2.38 % | $ 133 M | USA |
 |
Pulse Biosciences
PLSE
|
418 M | $ 14.86 | 1.92 % | $ 714 M | USA |
 |
ResMed
RMD
|
35.1 B | $ 244.44 | -0.07 % | $ 35.7 B | USA |
 |
Repligen Corporation
RGEN
|
10.8 M | $ 165.66 | -0.42 % | $ 9.23 M | USA |
 |
BioLife Solutions
BLFS
|
1.14 B | $ 25.41 | -0.2 % | $ 1.17 B | USA |
 |
STERIS plc
STE
|
24.2 B | $ 255.68 | 0.11 % | $ 25.2 B | USA |
 |
Stereotaxis
STXS
|
215 M | $ 2.43 | -0.82 % | $ 196 M | USA |
 |
STAAR Surgical Company
STAA
|
832 M | $ 23.63 | -1.25 % | $ 1.16 B | USA |
 |
Retractable Technologies
RVP
|
21 M | $ 0.82 | 0.22 % | $ 24.5 M | USA |
 |
Utah Medical Products
UTMD
|
247 M | $ 56.29 | -1.14 % | $ 204 M | USA |
 |
Teleflex Incorporated
TFX
|
6.21 B | $ 122.33 | 0.03 % | $ 5.73 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
3.5 B | $ 11.22 | 1.26 % | $ 2.28 B | USA |
 |
West Pharmaceutical Services
WST
|
15.4 B | $ 276.66 | -0.3 % | $ 20.2 B | USA |